Targeting Myc is a rational strategy – Hagop Youssoufian

Happy to share with you our poster that we presented this weekend at the European Hematology Association meeting in Frankfurt on a new potential treatment for Burkitt’s lymphoma, a highly aggressive subtype of lymphoma that was initially described in 1957! To date there is no specific therapy for this disease. Targeting Myc is a rational strategy. This study represents an ongoing and fruitful collaboration between Cothera Bioscience, Inc., and a multinational group of investigators led by Dr. S-S Yoon and his team from Seoul National University Hospital , Seoul, Korea.

https://clin.larvol.com/abstract-detail/EHA%202023/65462943

Source: Hagop Youssoufian / LinkedIn